Advancing Gender Equity at HDFCCC

Gender Equity Committee at UCSF

In 2021, the Gender Equity Committee was established at HDFCCC to promote and foster a supportive environment that advocates for the equitable advancement of women and gender minority leaders in cancer care, education, and research. The Gender Equity Committee is a sub-committee within the Office of Diversity, Equity, and Inclusion.

Leadership Opportunity: A Workshop for Values-based Leadership Development

Leadership  cohort at UCSF

In the 2022-2023 academic year, we held two day-long retreats with approximately sixty attendees from HDFCCC.

Due to the success of the program, we are offering two workshops, on Effective & Courageous Conversations and Effective Negotiations, to continue the longitudinal curriculum in September & October 2023. Each session will be offered at two different time slots to maximize the ability to attend (time slots in registration link below). These workshops will be offered in a hybrid fashion with Ethos session leader Claire Bonilla presenting virtually. We encourage attendance in person for networking opportunities and community. Refreshments will be provided, and registration is complimentary.

If you are interested in attending, please fill out this quick survey.

Registration is limited for these sessions and first come first serve. You are not required to have participated in the initial Values-Based Leadership workshop to participate.


  • CARE Advocate: The CARE advocate provides free and confidential services and explanation of each reporting option in details. This can be your first stop to discuss any issue confidentially, and they can support you to decide any next steps.  Contact: 415.502.8802 
  • Office of the Ombuds: This office can provide survivors with confidential information, including other resources. They can provide counseling and mediate difficult conversations. They are not mandatory reporters.  Contact: 415.502.9600 

Not Anonymous

  • Mandated reporters - managers, supervisors and certain employees, such as deans, faculty advisors, teaching assistants and resident advisors are required to report to the Title IX officer.
  • Office for the Prevention of Harassment & Discrimination (OPHD): UCSF’s Title IX Office.
    • This is where you file complaints relating to sexual harassment and sexual violence and harassment and discrimination based on other protected categories, including age, disability, gender, national origin, race, sexual orientation, etc.
    • Staffed by experts who will respond within a few days of receiving the complaint
    • If you submit a complaint as a mandatory reporter, you may not be notified of the outcome. 
    • Reports submitted to OPHD are kept as confidential as possible; however, a respondent has the right to know the identity of the complainant whenever a matter proceeds to a formal investigation. 
    • Encourage erring on the side of reporting, as complaints are logged and numerous reports of seemingly innocuous behavior may reveal a pattern of behavior that cumulatively results in a policy violation. 

Process for UCSF residents/fellows to report harassment or mistreatment:

  1. Go to the UCSF GME website.
  2. Click on “Well-Being and Mental Health Resources for Residents and Fellows” in the right sidebar
  3. Click the “Safe reporting” link in the right sidebar.
  • You can report an incident either anonymously or with contact information.
  • The form to report the incident is easy to use and the only required question is a description of what happened.
  • All reports are screened by GME staff, then (per the website) triaged to a faculty member unrelated to the submitting resident/fellow’s program for follow up.
  • Although reports can be submitted anonymously, contact information is required for follow up, which should occur within 3 business days.

Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist. Am Soc Clin Oncol Educ Book. 2023 May;43:e391516. Keenan BP, Barr E, Gleeson E, Greenberg CC, Temkin SM. PMID: 37155944. 

Microaggressions, Bias, and Equity in the Workplace: Why Does It Matter, and What Can Oncologists Do? Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-12. Velazquez AI, Gilligan TD, Kiel LL, Graff J, Duma N. PMID: 35649205

The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards. Oncologist. 2021 09; 26(9):779-786. Patel SR, St Pierre F, Velazquez AI, Ananth S, Durani U, Anampa-Guzmán A, Castillo K, Dhawan N, Oxentenko AS, Duma N. PMID: 34157172; PMCID: PMC8417845.

Pragmatic Solutions to Counteract the Regressive Effects of the COVID-19 Pandemic for Women in Academic Oncology. JAMA Oncol. 2021 06 01; 7(6):825-826. Keenan B, Jagsi R, Van Loon K. PMID: 33570543.  View in: PubMed 

The "Third Shift": A Path Forward to Recognizing and Funding Gender Equity Efforts. J Womens Health (Larchmt). 2020 11; 29(11):1359-1360. Santhosh L, Keenan BP, Jain S. PMID: 32744885; PMCID: PMC8020533. View in: PubMed  

Strategies for forming effective women's groups. Clin Teach. 2021 Apr; 18(2):126-130. Santhosh LHarleman E, Venado A, Farrand E, E Gilbreth M, Keenan BP, Thompson VVShah RJ. PMID: 33058547.

The Complex Problem of Women Trainees in Academic Medicine. J Hosp Med. 2019 03; 14(3):186-188. Keenan B, Santhosh LThompson VHarleman E. PMID: 30811328. View in: PubMed